 However, Sanofi-Pasteur stopped production last batch produced in January 2014 and expired in June 2016, making it necessary to use other snake antivenoms. Since the end of 2015, two new antivenoms are available in Cameroon where they are granted a provisional marketing authorization. Few clinical trials have evaluated the antivenoms currently available in Africa. 